Progentec Diagnostics
PrivateLast Round
Grant
Apr 9, 2026
Total Funding Raised
$6.48M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Progentec Diagnostics is a biotechnology company that develops proactive care solutions for systemic lupus erythematosus, multiple sclerosis, and other autoimmune diseases powered by proteomics and digital health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Patient Engagement, Clinical Trials, Telemedicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Progentec Diagnostics Comparables
Compare Progentec Diagnostics with similar companies based on industry and business-model similarity.
Progentec Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 9, 2026 | ||||
| Series A | Jan 8, 2020 | ||||
| Grant | Jul 25, 2019 | ||||
| Early Funding | Oct 31, 2018 | ||||
| Seed | Nov 27, 2017 |
Progentec Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Seed, Early Funding |
| Plains Ventures | Series A |
| Mayo Clinic Ventures | Seed |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
| OCA Ventures | Seed, Series A, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 45% MoM to 1.4K.
- Apr 9, 2026
Received grant from Oklahoma Center for the Advancement of Science and Technology.
Progentec Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Progentec Diagnostics's valuation, stock price, and market status.